Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,455.00
Bid: 1,456.00
Ask: 1,458.00
Change: 15.00 (1.04%)
Spread: 2.00 (0.137%)
Open: 1,440.00
High: 1,456.00
Low: 1,437.00
Prev. Close: 1,440.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: FTSE 100 stays above 8,000 as Centrica jumps

Thu, 16th Feb 2023 12:07

(Alliance News) - Stock prices in London were higher at midday on Thursday, with London's flagship index still trading above the 8,000 mark on the back of strong performances from Centrica and Relx.

"Having finally smashed through the 8,000 level on Wednesday, the FTSE 100 shows no signs that its batteries are running out of juice," said Russ Mould, investment director at AJ Bell.

The FTSE 100 index was up 7.80 points, or 0.1%, at 8,005.63. The FTSE 250 was up 69.09 points, or 0.3%, at 20,241.78, and the AIM All-Share was up 0.65 of a point, or 0.1%, at 870.18.

The Cboe UK 100 was up 0.1% at 801.44, the Cboe UK 250 was up 0.4% at 17,630.76, and the Cboe Small Companies was up 0.1% at 14,041.91.

The pound was quoted at USD1.2058 at midday on Wednesday in London, higher compared to USD1.2007 at the close on Thursday.

In London, Centrica remained the best blue-chip performer at midday on Thursday, rising 5.0%.

The British Gas-owner reported it swung to a statutory loss in 2022 on re-measurement and higher operating costs, but adjusted profit tripled as revenue surged 84%.

The Windsor, England-based firm revealed a pretax loss of GBP240 million in 2022, compared to a profit of GBP954 million in 2021.

The swing to a loss was on re-measurements after taxation, Centrica said, largely reflecting the revaluation of UK energy supply hedging positions due to wholesale gas and power price falls towards the end of the year. The cost for re-measurement and settlement of derivative energy contracts ballooned to GBP8.48 billion in 2022 from GBP434 million in 2021.

Centrica added it intends to extend its existing GBP250 million buyback programme, announced in November, by an additional GBP300 million. This would result in Centrica buying back 10% of its share capital, the power utility said.

Relx climbed 2.9%. The analytics firm upped its annual dividend, after it reported a better-than-expected 18% surge in revenue.

London-based Relx recorded revenue of GBP8.55 million in 2022, up 18% from GBP7.24 million in 2021. The company noted that Electronic revenue, representing 83% of total revenue, grew by 6%. This was also helped by a further recovery in face-to-face activity and a reducing print drag.

Revenue was also ahead of expectations. According to consensus cited by the Financial Times, Relx was expected to report revenue of GBP8.39 billion for 2022.

Pretax profit climbed by 20% to GBP2.49 billion from GBP2.08 billion.

Standard Chartered rose 2.4% as it reported double-digit rises in both annual profit and income.

The Asia-focused lender reported pretax profit of USD4.29 billion in 2022, up 28% from USD3.35 billion in 2021, as interest income jumped by nearly 50% to USD15.25 billion from USD10.25 billion. However, the bank had previously guided for a pretax profit of USD4.73 billion.

In the FTSE 250, Bank of Georgia jumped 6.2% as it reported a surge in pretax profit during 2022, as Georgia's economy grew rapidly, boosted by migration and capital relocation.

The Tbilisi-based lender said pretax profit in 2022 jumped 55% to GEL1.24 billion, about GBP394.9 million, from GEL801.9 million a year prior. Net interest income rose 24% to GEL1.18 billion from GEL953.9 million.

In addition, the bank said it aims to increase its share buyback and cancellation programme by up to GEL148 million.

Indivior plunged 13% as it reported a swing to a full-year loss due to a provision for litigation.

The Richmond, Virginia-based pharmaceutical firm swung to a pretax loss of USD95 million in 2022 from a profit of USD190 million in 2021, despite a jump by 14% in net revenue to USD901 million from USD791 million.

Indivior booked a USD290 million exceptional provision in 2022, as it navigates initial mediation sessions in late January regarding legacy civil multi-district antitrust litigation.

"Because these matters are in various stages, Indivior cannot predict with any certainty how these matters will ultimately be resolved, or the costs, or timing of such resolution. In particular, any final aggregate costs of these matters, whether resolved by settlement or trial, may be materially different from this provision," the company said.

Moneysupermarket dropped 2.9% despite reporting a rise in revenue thanks to its insurance, money and travel channels.

Chester, England-based price comparison site reported revenue of GBP387.6 million in 2022, up 22% from GBP316.7 million in 2021.

Insurance revenue increased by 8% to GBP172.0 million, Money revenue by 37% to GBP103.3 million, and Travel revenue more than tripled to GBP14.9 million. However, revenue in its Home Services arm, which includes energy price comparison, fell by 42% to GBP39.8 million.

Conditions in the wholesale energy market and the introduction of UK government support measures, including the Energy Price Guarantee, meaning it is unlikely that energy switching will return in 2023, Moneysupermarket said.

Elsewhere in London, Devro jumped 6.5% after it said it received an increased and "final" takeover offer from Saria Nederland, an indirect subsidiary of Saria SE & Co.

The sausage casing manufacturer said the revised proposal would see its shareholders receive 320p in cash for each share from Saria Nederland, alongside a second permitted interim dividend of 10p.

This would value the total share capital of Devro at around GBP564 million on a fully diluted basis, implying an enterprise value of GBP692 million.

In European equities on Thursday, the CAC 40 in Paris was up 0.9%, while the DAX 40 in Frankfurt was up 0.5%.

The Paris stock exchange bounced to a new record high on earlier on Thursday, the CAC 40 to 7,387.29 points, jumping over its previous record of 7,384.86 points reached in 2022.

The euro stood at USD1.0701 midday Thursday, higher against USD1.0669 at the London equities close on Wednesday. Against the yen, the dollar was trading at JPY133.85, lower compared to JPY134.32.

Stocks in New York were called lower, with the Dow Jones Industrial Average, the S&P 500 index, and the Nasdaq Composite all called 0.1% lower.

Brent oil was quoted at USD85.48 a barrel at midday in London on Thursday, up from USD84.07 late Wednesday. Gold was quoted at USD1,837.42 an ounce, higher against USD1,832.19.

Still to come on Thursday's economic calendar, the US will publish its weekly unemployment claims report at 1330 GMT alongside the producer price index.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 May 2024 13:48

UK shareholder meetings calendar - next 7 days

Friday 3 May 
Ashoka India Equity Investment Trust PLCGM re share issue
HSBC Holdings PLCAGM
Intercontinental Hotels Group PLCAGM
Mondi PLCAGM
More Acquisitions PLCAGM
Monday 6 May 
no events scheduled 
Tuesday 7 May 
Caledonia Mining Corp PLCAGM
CPPGroup PLCAGM
Just Group PLCAGM
Macfarlane Group PLC AGM
Plus500 LtdAGM
Supernova Digital Assets PLCAGM
Wednesday 8 May 
Airea PLCAGM
Antofagasta PLCAGM
Aston Martin Lagonda Global Holdings PLCAGM
Deltex Medical Group PLCAGM
Direct Line Insurance Group PLCAGM
Fidelity European Trust PLCAGM
Haleon PLCAGM
Jardine Matheson PLCAGM
JZ Capital Partners LtdEGM re investing in a secondary fund
Oscillate PLCAGM
Pershing Square Holdings LtdAGM
Rentokil Initial PLCAGM
WPP PLCAGM
Thursday 9 May 
Ascential PLCAGM
BAE Systems PLCAGM
Balfour Beatty PLCAGM
Barclays PLCAGM
CAB Payments Holdings PLCAGM
Catenai PLCGM re convertible loan note
Clarkson PLCAGM
FBD Holdings PLCAGM
Genel Energy plcAGM
Gym Group PLCAGM
Harbour Energy PLCAGM
Hiscox LtdAGM
IMI PLCAGM
Inchcape PLCAGM
Indivior PLCAGM
John Wood Group PLCAGM
Jupiter Fund Management PLCAGM
Logistics Development Group PLCAGM
Man Group PLCAGM
Morgan Advanced Materials PLCAGM
OSB Group PLCAGM
Public Policy Holding Co IncAGM
Rathbones Group PLCAGM
RM PLCAGM
Spire Healthcare Group PLCAGM
Synthomer PLCAGM
Uniphar PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
25 Apr 2024 09:23

Indivior shares down despite profit boost on planned shift to New York

(Alliance News) - Indivior PLC on Thursday saw its shares fall despite reporting a quarterly uptick in profit, as it announced plans to switch its listing to New York.

Read more
25 Apr 2024 08:56

Indivior reports first-quarter growth, confirms plans to shift main listing

(Sharecast News) - Addiction treatment specialist Indivior reported double-digit net revenue growth for the first quarter on Thursday, with total net revenue rising 12% year-on-year to $284m, as it confirmed its intention to shift its primary listing to the United States.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
18 Mar 2024 14:28

IN BRIEF: Indivior CCO Richard Simkin sells GBP1 million in shares

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 61,285 shares at GBP16.30 each, worth GBP998,946, in London on Thursday. Following this transaction, Simkin is now interested in 117,590 shares.

Read more
12 Mar 2024 09:29

LONDON BROKER RATINGS: UBS cuts abrdn price target but ups Darktrace's

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
8 Mar 2024 20:04

IN BRIEF: Indivior chief commercial officer sells GBP500,000 in shares

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 30,000 shares on Wednesday at average GBP17.22 each, for a total of GBP516,600.

Read more
7 Mar 2024 12:39

DIRECTOR DEALINGS: Oxford Nanopore Technologies top team buys shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and Thursday and not separately reported by Alliance News:

Read more
29 Feb 2024 19:10

Indivior says US court draws line on multi-district Suboxone case

(Alliance News) - Indivior PLC on Thursday said it received final court approval for a settlement of a multi-district Suboxone litigation case.

Read more
29 Feb 2024 09:47

Indivior receives settlement approval for antitrust litigation

(Sharecast News) - Pharmaceuticals business Indivior has received final court approval for a landmark settlement in an antitrust multi-district litigation with the direct purchaser class.

Read more
22 Feb 2024 16:53

LONDON MARKET CLOSE: European stocks boosted by ECB and Fed minutes

(Alliance News) - Stock prices in Europe closed higher on Thursday, on the back of minutes from the latest European Central Bank and US Federal Reserve meetings.

Read more
22 Feb 2024 16:26

London close: Stocks rise amid raft of solid earnings

(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.

Read more
22 Feb 2024 11:44

LONDON MARKET MIDDAY: Stocks boosted as UK recession "already" over

(Alliance News) - Stock prices in London were higher at midday Thursday, with the latest UK purchasing managers' index data indicating that the UK recession is "already" over.

Read more
22 Feb 2024 09:55

TOP NEWS: Indivior swings to profit as eyes primary listing move to US

(Alliance News) - Shares in Indivior PLC rose on Thursday, after the company said that strong sales of its flagship Sublocade treatment had pushed its revenue to new heights, and it added that it will begin talks with shareholders to move its primary listing across the Atlantic.

Read more
22 Feb 2024 08:26

Indivior planning to move primary listing to US, shares surge

(Sharecast News) - Indivior surged on Thursday after the opioid addiction treatment maker said it was planning to move its primary listing to the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.